Mozzillo N - Search Results

1

Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions. The Melanoma Cooperative Study.

Ascierto PA, Palmieri G, Celentano E, Parasole R, Caracò C, Daponte A, Chiofalo MG, Melucci MT, Mozzillo N, Satriano RA, Castello G. Ascierto PA, et al. Among authors: mozzillo n. Br J Dermatol. 2000 May;142(5):893-8. doi: 10.1046/j.1365-2133.2000.03468.x. Br J Dermatol. 2000. PMID: 10809845

2

The role of spectrophotometry in the diagnosis of melanoma.

Ascierto PA, Palla M, Ayala F, De Michele I, Caracò C, Daponte A, Simeone E, Mori S, Del Giudice M, Satriano RA, Vozza A, Palmieri G, Mozzillo N. Ascierto PA, et al. Among authors: mozzillo n. BMC Dermatol. 2010 Aug 13;10:5. doi: 10.1186/1471-5945-10-5. BMC Dermatol. 2010. PMID: 20707921 Free PMC article. Clinical Trial.

3

Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up.

Mozzillo N, Caracò C, Chiofalo MG, Celentano E, Lastoria S, Botti G, Ascierto PA. Mozzillo N, et al. Eur J Surg Oncol. 2004 May;30(4):440-3. doi: 10.1016/j.ejso.2004.01.020. Eur J Surg Oncol. 2004. PMID: 15063899

4

Melanoma: the role of surgery in the era of new therapies.

Mozzillo N, Ascierto PA. Mozzillo N, et al. J Transl Med. 2014 Jul 11;12:195. doi: 10.1186/1479-5876-12-195. J Transl Med. 2014. PMID: 25015684 Free PMC article. No abstract available.

5

Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimeters.

Caracò C, Celentano E, Lastoria S, Botti G, Ascierto PA, Mozzillo N. Caracò C, et al. Among authors: mozzillo n. Ann Surg Oncol. 2004 Mar;11(3 Suppl):198S-202S. doi: 10.1007/BF02523628. Ann Surg Oncol. 2004. PMID: 15023751

6

Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma. Melanoma Cooperative Group.

Ascierto PA, Palmieri G, Strazzullo M, Daponte A, Botti G, Satriano SM, Motti ML, Mozzillo N. Ascierto PA, et al. Among authors: mozzillo n. Ann Oncol. 2000 Apr;11(4):487-90. doi: 10.1023/a:1008375418507. Ann Oncol. 2000. PMID: 10847472 Free article. No abstract available.

7

Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.

Ascierto PA, Daponte A, Parasole R, Perrone F, Caracò C, Melucci M, Palmieri G, Napolitano M, Mozzillo N, Castello G. Ascierto PA, et al. Among authors: mozzillo n. Cancer. 2000 Oct 1;89(7):1490-4. doi: 10.1002/1097-0142(20001001)89:7<1490::aid-cncr11>3.0.co;2-v. Cancer. 2000. PMID: 11013362 Clinical Trial.

8

Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples. Results from 240 sentinel node biopsies.

Caracò C, Chiofalo MG, Niro J, Ascierto PA, Botti G, Lastoria S, Mozzillo N. Caracò C, et al. Among authors: mozzillo n. Tumori. 2002 May-Jun;88(3):S12-3. doi: 10.1177/030089160208800324. Tumori. 2002. PMID: 12365370

9

False negative and overall survival after sentinel lymph node biopsy in patients with cutaneous melanoma.

Caracò C, Mori S, Celentano E, Mozzillo N. Caracò C, et al. Among authors: mozzillo n. Suppl Tumori. 2005 May-Jun;4(3):S199. Suppl Tumori. 2005. PMID: 16437985 No abstract available.

10

Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.

Caracò C, Marone U, Botti G, Celentano E, Lastoria S, Mozzillo N. Caracò C, et al. Among authors: mozzillo n. Eur J Surg Oncol. 2006 Nov;32(9):970-3. doi: 10.1016/j.ejso.2006.07.007. Epub 2006 Sep 22. Eur J Surg Oncol. 2006. PMID: 16996239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters